The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
2-(Cyclopentyloxy)-9-(2,6-difluorobenzyl)-N-methyl-9H-purin-6-amine ID: ALA4758206
PubChem CID: 155803649
Max Phase: Preclinical
Molecular Formula: C18H19F2N5O
Molecular Weight: 359.38
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: CNc1nc(OC2CCCC2)nc2c1ncn2Cc1c(F)cccc1F
Standard InChI: InChI=1S/C18H19F2N5O/c1-21-16-15-17(24-18(23-16)26-11-5-2-3-6-11)25(10-22-15)9-12-13(19)7-4-8-14(12)20/h4,7-8,10-11H,2-3,5-6,9H2,1H3,(H,21,23,24)
Standard InChI Key: AWZRHMXFDZUHLF-UHFFFAOYSA-N
Molfile:
RDKit 2D
26 29 0 0 0 0 0 0 0 0999 V2000
25.3492 -19.2149 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
26.0588 -18.8055 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.0560 -17.9828 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
25.3474 -17.5776 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.6411 -18.8060 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.6378 -17.9895 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.8602 -17.7402 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
23.3829 -18.4028 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.8656 -19.0613 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
23.6162 -19.8396 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.8176 -20.0127 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.7672 -19.2130 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
27.4742 -18.8033 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.3447 -16.7604 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
26.0511 -16.3495 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.2739 -19.4064 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.4760 -19.5790 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.2259 -20.3579 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.7800 -20.9644 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.5759 -20.7886 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.1287 -21.3904 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
22.5259 -18.6290 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
28.2195 -19.1292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.7654 -18.5210 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.3556 -17.8139 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.5566 -17.9852 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5 1 1 0
1 2 2 0
2 3 1 0
3 4 2 0
4 6 1 0
5 6 2 0
6 7 1 0
7 8 2 0
8 9 1 0
9 5 1 0
9 10 1 0
10 11 1 0
2 12 1 0
12 13 1 0
4 14 1 0
14 15 1 0
11 16 2 0
16 17 1 0
17 18 2 0
18 19 1 0
19 20 2 0
20 11 1 0
20 21 1 0
16 22 1 0
13 23 1 0
23 24 1 0
24 25 1 0
25 26 1 0
26 13 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 359.38Molecular Weight (Monoisotopic): 359.1558AlogP: 3.52#Rotatable Bonds: 5Polar Surface Area: 64.86Molecular Species: NEUTRALHBA: 6HBD: 1#RO5 Violations: ┄HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 3.79CX LogP: 3.88CX LogD: 3.88Aromatic Rings: 3Heavy Atoms: 26QED Weighted: 0.76Np Likeness Score: -0.83
References 1. Nissink JWM,Bazzaz S,Blackett C,Clark MA,Collingwood O,Disch JS,Gikunju D,Goldberg K,Guilinger JP,Hardaker E,Hennessy EJ,Jetson R,Keefe AD,McCoull W,McMurray L,Olszewski A,Overman R,Pflug A,Preston M,Rawlins PB,Rivers E,Schimpl M,Smith P,Truman C,Underwood E,Warwicker J,Winter-Holt J,Woodcock S,Zhang Y. (2021) Generating Selective Leads for Mer Kinase Inhibitors-Example of a Comprehensive Lead-Generation Strategy., 64 (6.0): [PMID:33683117 ] [10.1021/acs.jmedchem.0c01904 ]